Ruby, Carl E <br/><br/>
OX40-enhanced tumor rejection and effector T cell differentiation decreases with age.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Feb 2009 
 - 1481-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.182.3.1481  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aging--immunology<br/>Animals<br/>Antibodies--administration & dosage<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Differentiation--immunology<br/>Cell Line, Tumor<br/>Colonic Neoplasms--immunology<br/>Female<br/>Graft Rejection--immunology<br/>Inflammation Mediators--administration & dosage<br/>Interleukin-12--administration & dosage<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Receptors, OX40--antagonists & inhibitors<br/>Sarcoma, Experimental--immunology